NO994078D0 - Forbindelser for inhibisjon av mavesyresekresjon - Google Patents

Forbindelser for inhibisjon av mavesyresekresjon

Info

Publication number
NO994078D0
NO994078D0 NO994078A NO994078A NO994078D0 NO 994078 D0 NO994078 D0 NO 994078D0 NO 994078 A NO994078 A NO 994078A NO 994078 A NO994078 A NO 994078A NO 994078 D0 NO994078 D0 NO 994078D0
Authority
NO
Norway
Prior art keywords
inhibition
compounds
gastric acid
acid secretion
secretion
Prior art date
Application number
NO994078A
Other languages
English (en)
Other versions
NO313009B1 (no
NO994078L (no
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO994078D0 publication Critical patent/NO994078D0/no
Publication of NO994078L publication Critical patent/NO994078L/no
Publication of NO313009B1 publication Critical patent/NO313009B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19994078A 1997-02-25 1999-08-24 Forbindelser for inhibering av mavesyresekresjon, farmasöytisk formulering inneholdende slike forbindelser, deresanvendelse og fremgangsmåte for deres fremstilling NO313009B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds
PCT/SE1998/000275 WO1998037080A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion

Publications (3)

Publication Number Publication Date
NO994078D0 true NO994078D0 (no) 1999-08-24
NO994078L NO994078L (no) 1999-08-24
NO313009B1 NO313009B1 (no) 2002-07-29

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994078A NO313009B1 (no) 1997-02-25 1999-08-24 Forbindelser for inhibering av mavesyresekresjon, farmasöytisk formulering inneholdende slike forbindelser, deresanvendelse og fremgangsmåte for deres fremstilling

Country Status (33)

Country Link
US (1) US6265415B1 (no)
EP (1) EP0971920B1 (no)
JP (1) JP2001512477A (no)
KR (1) KR20000075622A (no)
CN (1) CN1100056C (no)
AR (1) AR011134A1 (no)
AT (1) ATE218569T1 (no)
AU (1) AU723389B2 (no)
BR (1) BR9807457A (no)
CA (1) CA2280008A1 (no)
CZ (1) CZ291681B6 (no)
DE (1) DE69805787T2 (no)
DK (1) DK0971920T3 (no)
EE (1) EE04016B1 (no)
ES (1) ES2178169T3 (no)
HK (1) HK1024248A1 (no)
HU (1) HUP0000720A3 (no)
ID (1) ID22218A (no)
IL (1) IL131122A0 (no)
IS (1) IS1901B (no)
MY (1) MY118822A (no)
NO (1) NO313009B1 (no)
NZ (1) NZ336878A (no)
PL (1) PL190379B1 (no)
PT (1) PT971920E (no)
RU (1) RU2193036C2 (no)
SE (1) SE9700661D0 (no)
SK (1) SK283903B6 (no)
TR (1) TR199902060T2 (no)
TW (1) TW568907B (no)
UA (1) UA64741C2 (no)
WO (1) WO1998037080A1 (no)
ZA (1) ZA981134B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
GB2303855B (en) * 1994-07-01 1998-10-28 Rican Limited Helicobacter pylori antigenic protein preparation and immunoassays
EP0909323B1 (en) * 1996-01-04 2007-02-28 Novartis Vaccines and Diagnostics, Inc. Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) * 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
CA2458854A1 (en) * 2001-08-31 2003-03-06 Chiron Srl Helicobacter pylori vaccination
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE60317529T2 (de) 2002-09-19 2008-09-25 Schering Corp. Imidazopyridine als hemmstoffe cyclin abhängiger kinasen
KR101106905B1 (ko) * 2003-02-26 2012-01-25 수젠, 인크. 단백질 키나아제 억제제로서의 아미노헤테로아릴 화합물
PT1606261E (pt) 2003-03-10 2010-01-11 Nycomed Gmbh Novo processo para a preparação de roflumilast
EP1670795A1 (en) * 2003-09-18 2006-06-21 ALTANA Pharma AG Pharmacologically active imidazo 4,5-c pyridines
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
EP1787991B2 (en) * 2004-07-28 2020-06-24 Takeda Pharmaceutical Company Limited PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE
EP1784404B1 (en) 2004-09-03 2011-11-16 Yuhan Corporation Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
WO2006025714A1 (en) 2004-09-03 2006-03-09 Yuhan Corporation PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
CN101010321B (zh) 2004-09-03 2011-10-26 株式会社柳韩洋行 吡咯并[3,2-b]吡啶衍生物及其制备方法
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
EP1861095A1 (en) * 2005-03-24 2007-12-05 Glaxo Group Limited Derivatives of imidazo(1,2-a)pyridine useful as medicaments for treating gastrointestinal diseases
DE602006018354D1 (de) 2005-12-05 2010-12-30 Pfizer Prod Inc Verfahren zur behandlung von abnormalem zellwachstum
CA2632283C (en) 2005-12-05 2011-06-21 Pfizer Products Inc. Polymorphs of a c-met/hgfr inhibitor
US9309238B2 (en) * 2009-11-05 2016-04-12 University Of Notre Dame Du Lac Imidazo [1,2-a]pyridine compounds, synthesis thereof, and methods of using same
ES2597034T3 (es) 2011-05-30 2017-01-13 Astellas Pharma Inc. Compuesto de imidazopiridina
PT2927231T (pt) * 2012-11-30 2017-10-31 Astellas Pharma Inc Compostos de imidazopiridina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
CA2280008A1 (en) 1998-08-27
EE9900367A (et) 2000-04-17
HUP0000720A2 (hu) 2000-10-28
IS5148A (is) 1999-08-05
RU2193036C2 (ru) 2002-11-20
AU6314798A (en) 1998-09-09
MY118822A (en) 2005-01-31
EP0971920B1 (en) 2002-06-05
SK283903B6 (sk) 2004-04-06
CZ301499A3 (cs) 2000-02-16
IL131122A0 (en) 2001-01-28
PT971920E (pt) 2002-11-29
CN1248257A (zh) 2000-03-22
US6265415B1 (en) 2001-07-24
HK1024248A1 (en) 2000-10-05
NO313009B1 (no) 2002-07-29
ID22218A (id) 1999-09-16
DK0971920T3 (da) 2002-09-16
NZ336878A (en) 2001-05-25
WO1998037080A1 (en) 1998-08-27
DE69805787D1 (de) 2002-07-11
CN1100056C (zh) 2003-01-29
HUP0000720A3 (en) 2001-01-29
ATE218569T1 (de) 2002-06-15
EP0971920A1 (en) 2000-01-19
SE9700661D0 (sv) 1997-02-25
TW568907B (en) 2004-01-01
JP2001512477A (ja) 2001-08-21
PL335485A1 (en) 2000-04-25
TR199902060T2 (xx) 2000-02-21
EE04016B1 (et) 2003-04-15
ZA981134B (en) 1998-08-25
UA64741C2 (uk) 2004-03-15
KR20000075622A (ko) 2000-12-26
SK109999A3 (en) 2000-01-18
MX9907650A (es) 2002-12-13
IS1901B (is) 2003-11-20
NO994078L (no) 1999-08-24
BR9807457A (pt) 2000-04-25
AU723389B2 (en) 2000-08-24
CZ291681B6 (cs) 2003-04-16
DE69805787T2 (de) 2003-01-02
PL190379B1 (pl) 2005-12-30
ES2178169T3 (es) 2002-12-16
AR011134A1 (es) 2000-08-02

Similar Documents

Publication Publication Date Title
NO994078L (no) Forbindelser for inhibisjon av mavesyresekresjon
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20001728D0 (no) Fremgangsmåte for fremstilling av chirale forbindelser
NO20004288L (no) FremgangsmÕte til fremstilling av et beskyttet 4-aminometyl- pyrrolidin-3-on
NO20023937D0 (no) Fremgangsmåte for fremstilling av substituert tiazolidindion
NO20062796L (no) Fremgangsmate for fremstilling av en dihydroksyaminoforbindelse
GB2355657B (en) Inhibitors Of Gastric Acid Secretion
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO983784D0 (no) FremgangsmÕter for fremstilling av bifenyl-isoksasolsulfonamider
ID24327A (id) Produksi senyawa-senyawa avermektin
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
NO994131D0 (no) Fremgangsmåte for fremstilling av benzotiazolonforbindelser
NO972529D0 (no) Forbindelse for inhibering av mavesyresekresjon
FI981803A0 (fi) Menetelmä saostumien muodostumisen estämiseksi
FI972694A0 (fi) Uusi menetelmä sameridiinin valmistamiseksi
SI0971920T1 (en) Compounds for inhibition of gastric acid secretion
NO994793L (no) Fremgangsmåte for fremstilling av clavulansyre
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler
FI971913A0 (fi) Foerfarande foer oekning av en nedkylningsapparaturs nedkylningseffekt i en ishall
NO920033L (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser